Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCureVac N.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
CureVac N.V. Earnings Date And Information
CureVac N.V. last posted its earnings results on Monday, November 24th, 2025. The company reported $-0.1 earnings per share for the quarter, topping analysts' consensus estimates of $-0.17 by $0.07. The company had revenue of 54.13 M for the quarter and had revenue of 535.18 M for the year. CureVac N.V. has generated $1 earnings per share over the last year ($0.72 diluted earnings per share) and currently has a price-to-earnings ratio of 6.92. CureVac N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
CureVac N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/24/2025 | Q3 2025 | -$0.17 | $1.21 | 1.38 | $21.44 M | $54.13 M |
| 08/15/2025 | Q2 2025 | -$0.18 | -$0.26 | -0.08 | N/A | $1.25 M |
| 05/20/2025 | Q1 2025 | -$0.16 | -$0.23 | -0.07 | N/A | $893.00 K |
| 04/10/2025 | Q4 2024 | N/A | -$0.15 | N/A | N/A | $14.47 M |
| 11/12/2024 | Q3 2024 | $0.67 | $1.51 | 0.84 | N/A | $493.90 M |
| 08/15/2024 | Q2 2024 | -$0.28 | -$0.32 | -0.04 | N/A | $14.44 M |
| 05/23/2024 | Q1 2024 | -$0.22 | -$0.31 | -0.09 | N/A | $12.37 M |
| 04/24/2024 | Q4 2023 | N/A | -$0.38 | N/A | N/A | $21.99 M |
| 11/14/2023 | Q3 2023 | -$0.26 | -$0.22 | 0.04 | N/A | $16.48 M |
| 08/17/2023 | Q2 2023 | -$0.28 | -$0.30 | -0.02 | N/A | $7.58 M |
| 05/30/2023 | Q1 2023 | -$0.29 | -$0.27 | 0.02 | N/A | $7.13 M |
| 04/25/2023 | Q4 2022 | N/A | -$0.66 | N/A | N/A | $11.69 M |
| 11/17/2022 | Q3 2022 | N/A | -$0.26 | N/A | N/A | $11.21 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.31 | N/A | N/A | $20.15 M |
| 05/25/2022 | Q1 2022 | -$0.50 | -$0.08 | 0.42 | N/A | $24.37 M |
| 04/28/2022 | Q4 2021 | N/A | -$0.01 | N/A | N/A | $41.23 M |
| 12/17/2021 | Q3 2021 | N/A | -$0.80 | N/A | N/A | $29.34 M |
| 06/30/2021 | Q2 2021 | N/A | -$0.84 | N/A | N/A | $22.40 M |
| 03/31/2021 | Q1 2021 | N/A | -$0.62 | N/A | N/A | $10.03 M |
| 04/27/2021 | Q4 2020 | N/A | -$0.32 | N/A | N/A | $6.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CureVac N.V. Earnings: FAQ's
In the previous quarter, CureVac N.V. (:CVAC) reported $-0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.17 by $0.07.
The conference call for CureVac N.V.'s latest earnings report can be listened to online.
The conference call transcript for CureVac N.V.'s latest earnings report can be read online.
CureVac N.V. (:CVAC) has a recorded annual revenue of $535.18 M.
CureVac N.V. (:CVAC) has a recorded net income of $162.19 M.CureVac N.V. has generated $0.72 earnings per share over the last four quarters.
CureVac N.V. (:CVAC) has a price-to-earnings ratio of 6.92 and price/earnings-to-growth ratio is -0.2.